Further investigation by IHC staining in subcutaneous xenograft tumours also confirmed increased AM and YAP in DHT-treated tumours and decreased AM and YAP in MDV3100-treated tumours (Fig. 6d). The gene discussed is YAP1; the disease is neoplasm.